Hepatobiliary Associates of New York — Bayside, New York

Hepatobiliary Associates of New York is a clinical research site located in Bayside, New York, United States 11358.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

Hepatobiliary Associates of New York has participated in 3 clinical trials.

Therapeutic areas: Ulcerative Colitis, Crohn's Disease, Compensated Chronic Hepatitis B.

Sponsors: Millennium Pharmaceuticals, Inc., Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Hepatobiliary Associates of New York?

Hepatobiliary Associates of New York has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Hepatobiliary Associates of New York conducted?

Hepatobiliary Associates of New York has 3 clinical trials on record. Their work covers Ulcerative Colitis, Crohn's Disease, Compensated Chronic Hepatitis B.

Is Hepatobiliary Associates of New York accredited by Crixeo Health?

Hepatobiliary Associates of New York has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Hepatobiliary Associates of New York?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.